| |
| |
| |
Centre for Policy on Ageing | |
 | |
|
| Cost-effectiveness of exercise as a therapy for behavioural and psychological symptoms of dementia within the EVIDEM-E randomised controlled trial | | Author(s) | Francesco D'Amico, Amritpal Rehill, Martin Knapp |
| Journal title | International Journal of Geriatric Psychiatry, vol 31, no 6, June 2016 |
| Publisher | Wiley Blackwell, June 2016 |
| Pages | pp 656-665 |
| Source | www.orangejournal.org |
| Keywords | Dementia ; Behaviour disorders ; Symptoms ; Exercise ; Therapy ; Cost effectiveness. |
| Annotation | Although available evidence is modest, exercise could be beneficial in reducing behavioural and psychological symptoms of dementia. The present study aimed to evaluate the cost-effectiveness of a dyadic exercise regimen for individuals with dementia and their main carer as therapy for behavioural and psychological symptoms of dementia. The study analysed cost-effectiveness within a two-arm, pragmatic, randomised, controlled, single-blind, parallel-group trial of a dyadic exercise regimen (individually tailored, for 20_30 minutes at least five times per week). The study then randomised 131 community-dwelling individuals with dementia and clinically significant behavioural and psychological symptoms with a carer willing and able to participate in the exercise regimen. 52 dyads provided sufficient cost data for analyses. Mean intervention cost was £284 per dyad. For the subsample of 52 dyads, the intervention group had significantly higher mean cost from a societal perspective, but costs were not significantly different from a health and social care perspective. The exercise intervention was more cost-effective than treatment as usual from both societal and health and social care perspectives for the measure of behavioural and psychological symptoms (Neuropsychiatric Inventory). It did not appear cost-effective in terms of cost per quality-adjusted life year gain. The exercise intervention had the potential to be seen as cost-effective when considering behavioural and psychological symptoms but did not appear cost-effective when considering quality-adjusted life year gains. (JL). |
| Accession Number | CPA-160520209 A |
| Classmark | EA: EP: CT: CEA: LO: WEC |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|
|